Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
Clinical trial update on the efficacy, safety and tolerability of Targretin (bexarotene) capsules in advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gefitinib in previously untreated stage IIIB or IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating imatinib mesylate and bevacizumab after first-line chemotherapy in stage IIIB or IV non-small cell lung cancer comp…
-
CLINICAL_TRIALS trial_result · 2013-05-06Clinical Trial Update: Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 study evaluating lomustine in stage III or stage IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluated paclitaxel plus radiation therapy in patients with untreated stage III non-small cell lung cancer, and the trial h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating the combination of erlotinib and pertuzumab in relapsed non-small cell lung cancer. The trial is completed with res…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Pyrazoloacridine in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the effectiveness and safety of Pyrazoloacridine in patients with advanced Non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated the combination of gefitinib and celecoxib in patients with refractory non-small cell lung cancer; the study has c…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study evaluating carboplatin/paclitaxel with ABT-869 (linifanib) in advanced or metastatic non-small cell lung cancer. The study sta…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating the combination of celecoxib and docetaxel in patients with advanced non-small cel…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: A Study to Evaluate Pazopanib in Comparison to Pemetrexed in Maintenance Setting in Non-progressing Subjects With Metastatic Stage IVA and IVB Non-squamous Non-small Cell Lung Cancer (NSCLC) Population [Phase 2]
Phase 2 maintenance trial in non-progressing metastatic stage IVA/IVB non-squamous non-small cell lung cancer comparing pazopanib to pemetre…
-
CLINICAL_TRIALS trial_result · 2013-04-29Clinical Trial Update: Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of celecoxib and docetaxel in patients with non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-24Clinical Trial Update: Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer [Phase 1, Phase 2]
A phase 1/2 study evaluated CP-751,871 with paclitaxel and carboplatin in advanced non-small cell lung cancer; the trial has been completed …
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Erlotinib Hydrochloride With or Without Cixutumumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This Phase 1/2 clinical trial tested erlotinib alone or with cixutumumab in patients with stage III or stage IV non-small cell lung cancer; …
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: Empyema Following Pneumonectomy for Non Small Cell Lung Cancer (NSCLC)
A completed clinical trial record related to empyema following pneumonectomy in non-small cell lung cancer patients.
-
CLINICAL_TRIALS trial_result · 2013-04-22Clinical Trial Update: Alimta® Versus Its Combination With Carboplatin in Advanced Non-small-cell Lung Cancer in Patients Performance Status 2 [Phase 3]
Phase 3 trial comparing pemetrexed (Alimta) alone versus pemetrexed with carboplatin in advanced non-small cell lung cancer patients with pe…
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating radiation therapy and stereotactic radiosurgery with or without temozolomide or erlotinib for brain metastases fr…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of CI-1040 in advanced breast cancer, colorectal cancer, pancreatic cancer, and non-small cell lung cancer has completed. Sp…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer [Phase 1]
Phase 1 study of CP-751,871 in combination with carboplatin and paclitaxel in advanced non-small cell lung cancer. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors [Phase 1]
Phase 1 safety study of XL147 (SAR245408) in combination with paclitaxel and carboplatin in adults with solid tumors has been completed, inv…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial update for ABT-869 (vatalanib) in subjects with advanced Non-Small Cell Lung Cancer indicates the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) [Phase 1, Phase 2]
This clinical trial update reports results from a Phase I/II study of paclitaxel, carboplatin, and YM155 (survivin suppressor) in patients w…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Erlotinib for advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-28Clinical Trial Update: Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial comparing combination chemotherapy to no treatment after surgical resection in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-22Clinical Trial Update: Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial comparing 99mTc-EC-DG SPECT/CT with 18F FDG PET/CT in patients with Non-small cell lung cancer has completed.